Skip to main content
. Author manuscript; available in PMC: 2007 Mar 15.
Published in final edited form as: Brain Res Mol Brain Res. 2005 Apr 4;134(2):215–225. doi: 10.1016/j.molbrainres.2004.10.044

Fig. 5.

Fig. 5

Neuroprotection induced by THC was CB1 receptor-independent. The CB1 receptor antagonist SR 141716A (2 μM) did not abolish neuroprotection by THC from NMDA-induced toxicity. *** and +++ indicate p< 0.001, respectively, as compared to 7.5 mM NMDA or 10 mM NMDA alone. Data are means ± S.E.M.